Rajwanth Veluswamy has Medical Oncology as his primary medical specialty. Their primary office is: 10 E 102nd St in New York, New York.
There is an additional office location, for a total of two, for Rajwanth Veluswamy that can be viewed further down.
They're a part of the: Icahn School Of Medicine At Mount Sinai medical group which has around 2,318 members. You can call their office at 212-844-8288 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Rajwanth Veluswamy
Icahn School Of Medicine At Mount Sinai
10 E 102nd St
New York, New York 10029
212-844-8288
Phone: 212-844-8288
Enter a starting address:
Additional Medical Specialties Include:
INTERNAL MEDICINE
Medical School: Sorry, his university is not listed
Graduation Year: 2006
The Primary Medical Specialty for Rajwanth Veluswamy is listed as: Medical Oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 5294984001
NPI #: 1659508448
NPI Created On: 06/18/2009
NPI Last Updated Listed as: 07/21/2022
Primary Taxonomy Code: 207R00000X
License Number:
265791
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $109
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 813338017
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: TABRECTA
Open Associated Drug #1: 0078-0709-56
Payments Total: $2,680
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 846699453
Being Disputed:: No
Product Related: No
Payments Total: $4,020
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 846699455
Being Disputed:: No
Product Related: No
Payments Total: $4,690
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 846699457
Being Disputed:: No
Product Related: No
Payments Total: $100
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Context of payment:: Speaker Fee
Record ID:: 829332167
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: TAGRISSO
Open Associated Drug #1: 0310-1349-30
Payments Total: $2,000
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Context of payment:: Speaker Fee
Record ID:: 829333629
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: TAGRISSO
Open Associated Drug #1: 0310-1349-30
Payments Total: $250
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Context of payment:: Speaker Fee
Record ID:: 829381185
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: TAGRISSO
Open Associated Drug #1: 0310-1349-30
Payments Total: $76
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Context of payment:: Speaker Expenses
Record ID:: 829398789
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: IMFINZI
Open Associated Drug #1: 0310-4500-12
Payments Total: $2,000
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Third party is a Charity:: No
Context of payment:: Speaker Fee
Record ID:: 829425569
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: IMFINZI
Open Associated Drug #1: 0310-4500-12
Payments Total: $83
Number of Payments:: 1
Form of Payment: In-kind items and services
Travel and Lodging City: Brooklyn
Travel and Lodging State: NY
Travel and Lodging Country: United States
Third party is a Charity:: No
Context of payment:: Speaker Expenses
Record ID:: 829855907
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: IMFINZI
Open Associated Drug #1: 0310-4500-12
1. Icahn School Of Medicine At Mount Sinai
2510 30th Ave
Astoria, NY 11102
Group Members: 2,318
Phone: 212-844-8288
Enter a starting address:
520 E 70th St
New-york, NY
Weill Medical College Of Cornell
1275 York Ave
New-york, NY
Memorial Hematology Lymphoma Group
550 1st Ave
New-york, NY
New York University
5 E 98th St 12th Floor
New-york, NY
Icahn School Of Medicine At Mount Sinai
5 E 98th St
New-york, NY
Icahn School Of Medicine At Mount Sinai
1275 York Ave
New-york, NY
Memorial Neurology Group
8201 37th Ave
Jackson Heights Ny 11372-7011
Icahn School Of Medicine At Mount Sinai
Medical Oncology
1302 Amsterdam Ave
New York Ny 10027-4244
Icahn School Of Medicine At Mount Sinai
Cardiovascular Disease (cardiology)
1 Gustave L Levy Pl
New York Ny 10029-6504
Icahn School Of Medicine At Mount Sinai
Cardiovascular Disease (cardiology)
1 Gustave L Levy Pl
New York Ny 10029-6504
Icahn School Of Medicine At Mount Sinai
Hospitalist
1000 10th Ave
New York Ny 10019-1147
Icahn School Of Medicine At Mount Sinai
Hospitalist
1111 Amsterdam Ave
New York Ny 10025-1716
Icahn School Of Medicine At Mount Sinai
Hospitalist
View all 2,318 members of Icahn School Of Medicine At Mount Sinai medical group